Peter Xia is a National MSL Manager at LEO Pharma since April 2019, specializing in regional field medical leadership and scientific engagement with key opinion leaders in Ontario and Atlantic regions, while supporting a portfolio of 8 products across various therapeutic areas. Prior to this role, Peter completed an Industrial Pharmacy Residency in Market Access at Biogen, where significant contributions included budget impact analyses and negotiations for SPINRAZA®, the first treatment in spinal muscular atrophy. Peter began a professional journey in pharmacy at Shoppers Drug Mart and ClaimSecure Inc., where analytical skills were developed through advanced pharmacy practice and contributions to drug reviews. Educational credentials include a Doctor of Pharmacy (PharmD) from the University of Toronto and a Bachelor of Science in Microbiology and Immunology from McGill University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices